 | • レポートコード：MRC2-11QY08086 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は吐き気薬のグローバル市場について調査・分析したレポートです。種類別（制酸剤、拮抗薬、抗不安薬、ステロイド、カンナビノイド）市場規模、用途別（病院、診療所、製薬会社）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別吐き気薬の競争状況、市場シェア ・世界の吐き気薬市場：種類別市場規模 2015年-2020年（制酸剤、拮抗薬、抗不安薬、ステロイド、カンナビノイド） ・世界の吐き気薬市場：種類別市場規模予測 2021年-2026年（制酸剤、拮抗薬、抗不安薬、ステロイド、カンナビノイド） ・世界の吐き気薬市場：用途別市場規模 2015年-2020年（病院、診療所、製薬会社） ・世界の吐き気薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、製薬会社） ・北米の吐き気薬市場分析：米国、カナダ ・ヨーロッパの吐き気薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの吐き気薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の吐き気薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの吐き気薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Sanofi、TESARO、Roche、Pfizer、GlaxoSmithKline、ANI Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat.
Many pharmacologic medications are available for the treatment of nausea. There is no medication that is clearly superior to other medications for all cases of nausea. The choice of antiemetic medication may be based on the situation during which the person experiences nausea. For people with motion sickness and vertigo, antihistamines and anticholinergics such as meclizine and scopolamine are particularly effective. Nausea and vomiting associated with migraine headaches respond best to dopamine antagonists such as metoclopramide, prochlorperazine, and chlorpromazine. In cases of gastroenteritis, serotonin antagonists such as ondansetron were found to suppress nausea and vomiting, as well as reduce the need for IV fluid resuscitation.
Market Analysis and Insights: Global Nausea Medicine Market
The global Nausea Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nausea Medicine Scope and Market Size
Nausea Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nausea Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nausea Medicine market is segmented into
Antacids
Antagonists
Anti-Anxiety Drugs
Steroids
Cannabinoids
Segment by Application, the Nausea Medicine market is segmented into
Hospital
Clinics
Pharmaceutical Companies
Regional and Country-level Analysis
The Nausea Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nausea Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nausea Medicine Market Share Analysis
Nausea Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nausea Medicine business, the date to enter into the Nausea Medicine market, Nausea Medicine product introduction, recent developments, etc.
The major vendors covered:
Merck
Sanofi
TESARO
Roche
Pfizer
GlaxoSmithKline
ANI Pharmaceuticals
…
1 Study Coverage
1.1 Nausea Medicine Product Introduction
1.2 Market Segments
1.3 Key Nausea Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nausea Medicine Market Size Growth Rate by Type
1.4.2 Antacids
1.4.3 Antagonists
1.4.4 Anti-Anxiety Drugs
1.4.5 Steroids
1.4.6 Cannabinoids
1.5 Market by Application
1.5.1 Global Nausea Medicine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nausea Medicine Market Size, Estimates and Forecasts
2.1.1 Global Nausea Medicine Revenue 2015-2026
2.1.2 Global Nausea Medicine Sales 2015-2026
2.2 Global Nausea Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Nausea Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nausea Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nausea Medicine Competitor Landscape by Players
3.1 Nausea Medicine Sales by Manufacturers
3.1.1 Nausea Medicine Sales by Manufacturers (2015-2020)
3.1.2 Nausea Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Nausea Medicine Revenue by Manufacturers
3.2.1 Nausea Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Nausea Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nausea Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nausea Medicine Revenue in 2019
3.2.5 Global Nausea Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nausea Medicine Price by Manufacturers
3.4 Nausea Medicine Manufacturing Base Distribution, Product Types
3.4.1 Nausea Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nausea Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Nausea Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nausea Medicine Market Size by Type (2015-2020)
4.1.1 Global Nausea Medicine Sales by Type (2015-2020)
4.1.2 Global Nausea Medicine Revenue by Type (2015-2020)
4.1.3 Nausea Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nausea Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Nausea Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Nausea Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Nausea Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nausea Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nausea Medicine Market Size by Application (2015-2020)
5.1.1 Global Nausea Medicine Sales by Application (2015-2020)
5.1.2 Global Nausea Medicine Revenue by Application (2015-2020)
5.1.3 Nausea Medicine Price by Application (2015-2020)
5.2 Nausea Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Nausea Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Nausea Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Nausea Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Nausea Medicine by Country
6.1.1 North America Nausea Medicine Sales by Country
6.1.2 North America Nausea Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nausea Medicine Market Facts & Figures by Type
6.3 North America Nausea Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Nausea Medicine by Country
7.1.1 Europe Nausea Medicine Sales by Country
7.1.2 Europe Nausea Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nausea Medicine Market Facts & Figures by Type
7.3 Europe Nausea Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Nausea Medicine by Region
8.1.1 Asia Pacific Nausea Medicine Sales by Region
8.1.2 Asia Pacific Nausea Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nausea Medicine Market Facts & Figures by Type
8.3 Asia Pacific Nausea Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Nausea Medicine by Country
9.1.1 Latin America Nausea Medicine Sales by Country
9.1.2 Latin America Nausea Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nausea Medicine Market Facts & Figures by Type
9.3 Central & South America Nausea Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Nausea Medicine by Country
10.1.1 Middle East and Africa Nausea Medicine Sales by Country
10.1.2 Middle East and Africa Nausea Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nausea Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Nausea Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Nausea Medicine Products Offered
11.1.5 Merck Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Nausea Medicine Products Offered
11.2.5 Sanofi Related Developments
11.3 TESARO
11.3.1 TESARO Corporation Information
11.3.2 TESARO Description and Business Overview
11.3.3 TESARO Sales, Revenue and Gross Margin (2015-2020)
11.3.4 TESARO Nausea Medicine Products Offered
11.3.5 TESARO Related Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description and Business Overview
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Nausea Medicine Products Offered
11.4.5 Roche Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Nausea Medicine Products Offered
11.5.5 Pfizer Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Nausea Medicine Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 ANI Pharmaceuticals
11.7.1 ANI Pharmaceuticals Corporation Information
11.7.2 ANI Pharmaceuticals Description and Business Overview
11.7.3 ANI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ANI Pharmaceuticals Nausea Medicine Products Offered
11.7.5 ANI Pharmaceuticals Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Nausea Medicine Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Nausea Medicine Market Estimates and Projections by Region
12.1.1 Global Nausea Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Nausea Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Nausea Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Nausea Medicine Sales Forecast (2021-2026)
12.2.2 North America: Nausea Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Nausea Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Nausea Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Nausea Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Nausea Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Nausea Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nausea Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nausea Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nausea Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nausea Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Nausea Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Nausea Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Nausea Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Nausea Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nausea Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nausea Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nausea Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nausea Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nausea Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nausea Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Nausea Medicine Market Segments
Table 2. Ranking of Global Top Nausea Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nausea Medicine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antacids
Table 5. Major Manufacturers of Antagonists
Table 6. Major Manufacturers of Anti-Anxiety Drugs
Table 7. Major Manufacturers of Steroids
Table 8. Major Manufacturers of Cannabinoids
Table 9. Global Nausea Medicine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Nausea Medicine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Nausea Medicine Sales by Regions 2015-2020 (K Units)
Table 12. Global Nausea Medicine Sales Market Share by Regions (2015-2020)
Table 13. Global Nausea Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Nausea Medicine Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Nausea Medicine Sales Share by Manufacturers (2015-2020)
Table 16. Global Nausea Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Nausea Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nausea Medicine as of 2019)
Table 18. Nausea Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Nausea Medicine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Nausea Medicine Price (2015-2020) (USD/Unit)
Table 21. Nausea Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nausea Medicine Product Type
Table 23. Date of International Manufacturers Enter into Nausea Medicine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 26. Global Nausea Medicine Sales Share by Type (2015-2020)
Table 27. Global Nausea Medicine Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Nausea Medicine Revenue Share by Type (2015-2020)
Table 29. Nausea Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 31. Global Nausea Medicine Sales Share by Application (2015-2020)
Table 32. North America Nausea Medicine Sales by Country (2015-2020) (K Units)
Table 33. North America Nausea Medicine Sales Market Share by Country (2015-2020)
Table 34. North America Nausea Medicine Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Nausea Medicine Revenue Market Share by Country (2015-2020)
Table 36. North America Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 37. North America Nausea Medicine Sales Market Share by Type (2015-2020)
Table 38. North America Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 39. North America Nausea Medicine Sales Market Share by Application (2015-2020)
Table 40. Europe Nausea Medicine Sales by Country (2015-2020) (K Units)
Table 41. Europe Nausea Medicine Sales Market Share by Country (2015-2020)
Table 42. Europe Nausea Medicine Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Nausea Medicine Revenue Market Share by Country (2015-2020)
Table 44. Europe Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 45. Europe Nausea Medicine Sales Market Share by Type (2015-2020)
Table 46. Europe Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 47. Europe Nausea Medicine Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Nausea Medicine Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Nausea Medicine Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Nausea Medicine Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Nausea Medicine Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Nausea Medicine Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Nausea Medicine Sales Market Share by Application (2015-2020)
Table 56. Latin America Nausea Medicine Sales by Country (2015-2020) (K Units)
Table 57. Latin America Nausea Medicine Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Nausea Medicine Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Nausea Medicine Revenue Market Share by Country (2015-2020)
Table 60. Latin America Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 61. Latin America Nausea Medicine Sales Market Share by Type (2015-2020)
Table 62. Latin America Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 63. Latin America Nausea Medicine Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Nausea Medicine Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Nausea Medicine Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Nausea Medicine Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Nausea Medicine Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nausea Medicine Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Nausea Medicine Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Nausea Medicine Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Nausea Medicine Sales Market Share by Application (2015-2020)
Table 72. Merck Corporation Information
Table 73. Merck Description and Major Businesses
Table 74. Merck Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Merck Product
Table 76. Merck Recent Development
Table 77. Sanofi Corporation Information
Table 78. Sanofi Description and Major Businesses
Table 79. Sanofi Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Sanofi Product
Table 81. Sanofi Recent Development
Table 82. TESARO Corporation Information
Table 83. TESARO Description and Major Businesses
Table 84. TESARO Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. TESARO Product
Table 86. TESARO Recent Development
Table 87. Roche Corporation Information
Table 88. Roche Description and Major Businesses
Table 89. Roche Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Roche Product
Table 91. Roche Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Major Businesses
Table 94. Pfizer Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. GlaxoSmithKline Corporation Information
Table 98. GlaxoSmithKline Description and Major Businesses
Table 99. GlaxoSmithKline Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Recent Development
Table 102. ANI Pharmaceuticals Corporation Information
Table 103. ANI Pharmaceuticals Description and Major Businesses
Table 104. ANI Pharmaceuticals Nausea Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. ANI Pharmaceuticals Product
Table 106. ANI Pharmaceuticals Recent Development
Table 107. Global Nausea Medicine Sales Forecast by Regions (2021-2026) (K Units)
Table 108. Global Nausea Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Nausea Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Nausea Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Nausea Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 112. North America: Nausea Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Nausea Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 114. Europe: Nausea Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Nausea Medicine Sales Forecast by Region (2021-2026) (K Units)
Table 116. Asia Pacific: Nausea Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Nausea Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 118. Latin America: Nausea Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Nausea Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 120. Middle East and Africa: Nausea Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Nausea Medicine Players
Table 125. Nausea Medicine Customers List
Table 126. Nausea Medicine Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Nausea Medicine Product Picture
Figure 2. Global Nausea Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Antacids Product Picture
Figure 4. Antagonists Product Picture
Figure 5. Anti-Anxiety Drugs Product Picture
Figure 6. Steroids Product Picture
Figure 7. Cannabinoids Product Picture
Figure 8. Global Nausea Medicine Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinics
Figure 11. Pharmaceutical Companies
Figure 12. Nausea Medicine Report Years Considered
Figure 13. Global Nausea Medicine Market Size 2015-2026 (US$ Million)
Figure 14. Global Nausea Medicine Sales 2015-2026 (K Units)
Figure 15. Global Nausea Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Nausea Medicine Sales Market Share by Region (2015-2020)
Figure 17. Global Nausea Medicine Sales Market Share by Region in 2019
Figure 18. Global Nausea Medicine Revenue Market Share by Region (2015-2020)
Figure 19. Global Nausea Medicine Revenue Market Share by Region in 2019
Figure 20. Global Nausea Medicine Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Nausea Medicine Revenue in 2019
Figure 22. Nausea Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Nausea Medicine Sales Market Share by Type (2015-2020)
Figure 24. Global Nausea Medicine Sales Market Share by Type in 2019
Figure 25. Global Nausea Medicine Revenue Market Share by Type (2015-2020)
Figure 26. Global Nausea Medicine Revenue Market Share by Type in 2019
Figure 27. Global Nausea Medicine Market Share by Price Range (2015-2020)
Figure 28. Global Nausea Medicine Sales Market Share by Application (2015-2020)
Figure 29. Global Nausea Medicine Sales Market Share by Application in 2019
Figure 30. Global Nausea Medicine Revenue Market Share by Application (2015-2020)
Figure 31. Global Nausea Medicine Revenue Market Share by Application in 2019
Figure 32. North America Nausea Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Nausea Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Nausea Medicine Sales Market Share by Country in 2019
Figure 35. North America Nausea Medicine Revenue Market Share by Country in 2019
Figure 36. U.S. Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Nausea Medicine Market Share by Type in 2019
Figure 41. North America Nausea Medicine Market Share by Application in 2019
Figure 42. Europe Nausea Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Nausea Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Nausea Medicine Sales Market Share by Country in 2019
Figure 45. Europe Nausea Medicine Revenue Market Share by Country in 2019
Figure 46. Germany Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Nausea Medicine Market Share by Type in 2019
Figure 57. Europe Nausea Medicine Market Share by Application in 2019
Figure 58. Asia Pacific Nausea Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Nausea Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Nausea Medicine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Nausea Medicine Revenue Market Share by Region in 2019
Figure 62. China Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Nausea Medicine Market Share by Type in 2019
Figure 85. Asia Pacific Nausea Medicine Market Share by Application in 2019
Figure 86. Latin America Nausea Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Nausea Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Nausea Medicine Sales Market Share by Country in 2019
Figure 89. Latin America Nausea Medicine Revenue Market Share by Country in 2019
Figure 90. Mexico Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Nausea Medicine Market Share by Type in 2019
Figure 97. Latin America Nausea Medicine Market Share by Application in 2019
Figure 98. Middle East and Africa Nausea Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Nausea Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Nausea Medicine Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Nausea Medicine Revenue Market Share by Country in 2019
Figure 102. Turkey Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Nausea Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Nausea Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Nausea Medicine Market Share by Type in 2019
Figure 109. Middle East and Africa Nausea Medicine Market Share by Application in 2019
Figure 110. North America Nausea Medicine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Nausea Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Nausea Medicine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Nausea Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Nausea Medicine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Nausea Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Nausea Medicine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Nausea Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Nausea Medicine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Nausea Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
術後悪心嘔吐（PONV）の世界市場（～2026年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…- 化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market The global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemoth…
- 化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…
- ゲノム医療の世界市場（～2026年） Market Analysis and Insights: Global Genomic Medicine Market The global Genomic Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genomic Medicine Scope and Market Size Genomic Medicine market is segmented by Ty…
- ニキビ薬の世界市場（～2026年） Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. It generally affects skin with comparatively high…